Compliance Rate
Compliance Rate
0.0%
Compliant submissions
0
Incompliant submissions
1
Total trials
1
My Organizations' Clinical Trials
Showing 325 of 568 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/31/10
End: 01/31/13
Due: 01/31/14
Phase: N/A
Priority: Normal
Start: 02/28/10
End: 12/31/30
Due: 12/31/31
Phase: N/A
Priority: Normal
Start: 01/31/98
End: 07/31/11
Due: 07/31/12
Phase: N/A
Priority: Normal
Start: 01/31/08
End: 03/31/11
Due: 03/31/12
Phase: N/A
Priority: Normal
Start: 04/30/08
End: 03/31/12
Due: 03/31/13
Phase: N/A
Priority: Normal
Start: 10/31/17
End: 10/06/21
Due: 10/06/22
Phase: N/A
Priority: Normal
Start: 09/01/20
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 05/01/23
End: 06/01/26
Due: 06/01/27
Phase: N/A
Priority: Normal
Start: 09/10/20
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 09/30/12
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 09/01/21
End: 09/01/25
Due: 09/01/26
Phase: N/A
Priority: Normal
Start: 02/28/11
End: 03/31/12
Due: 03/31/13
Phase: N/A
Priority: Normal
Start: 05/31/13
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 04/02/24
End: 08/01/25
Due: 08/01/26
Phase: N/A
Priority: Normal
Start: 06/21/18
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 12/21/20
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 01/02/18
End: 10/06/21
Due: 10/06/22
Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced Asthma
Phase: N/A
Priority: Normal
Start: 02/28/10
End: 04/30/14
Due: 04/30/15
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 05/31/22
Due: 05/31/23
Phase: N/A
Priority: Normal
Start: 05/09/24
End: 04/01/26
Due: 04/01/27
Phase: N/A
Priority: Normal
Start: 12/31/88
End: 10/31/93
Due: 10/31/94
Phase: N/A
Priority: Normal
Start: 10/12/23
End: 06/30/27
Due: 06/30/28
Phase: N/A
Priority: Normal
Start: 10/31/07
End: 02/29/08
Due: 02/28/09
Phase: N/A
Priority: Normal
Start: 11/01/19
End: 10/04/21
Due: 10/04/22
Phase: N/A
Priority: Normal
Start: 07/05/20
End: 12/31/21
Due: 12/31/22